ABAT and colorectal cancer: The present study identified six hub targets—GOT1, CYP2C9, CYP34, CYP1A2, CA2, and ABAT—that are involved in five core pathways related to HQD’s effects on malignant progression in colorectal cancer liver metastases, integrating transcriptomic and metabolomic analyses.